ORBIMED ADVISORS LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$5.1B
Holdings
116
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (116 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | VIGLVIGIL NEUROSCIENCE INC | 448,891 | $4.4B | 86.27% | |
| 102 | SRRKSCHOLAR ROCK HLDG CORP | 515,000 | $4.1B | 80.88% | |
| 103 | NXTCNEXTCURE INC | 2,711,013 | $4.0B | 78.76% | |
| 104 | —SYNLOGIC INC | 6,029,995 | $3.8B | 74.81% | |
| 105 | CMMBCHEMOMAB THERAPEUTICS LTD | 2,241,274 | $3.6B | 69.96% | |
| 106 | EPIEURESSA PHARMA INC | 1,198,337 | $3.6B | 69.87% | |
| 107 | TARAPROTARA THERAPEUTICS INC | 793,558 | $2.5B | 48.76% | |
| 108 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 1,541,000 | $2.1B | 42.05% | |
| 109 | AFIBACUTUS MED INC | 2,648,386 | $2.0B | 39.20% | |
| 110 | RVNCEURREVANCE THERAPEUTICS INC | 50,000 | $1.6B | 31.62% | |
| 111 | HRTXHERON THERAPEUTICS INC | 802,700 | $1.2B | 23.79% | |
| 112 | NKTREURNEKTAR THERAPEUTICS | 1,579,059 | $1.1B | 21.79% | Call |
| 113 | PHGEBIOMX INC | 3,161,489 | $964.3M | 18.93% | |
| 114 | —SINGULAR GENOMICS SYSTEMS IN | 540,697 | $654.2M | 12.84% | |
| 115 | ALTALTIMMUNE INC | 150,600 | $635.5M | 12.48% | Call |
| 116 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 1,797,221 | $521.2M | 10.23% | |
| 117 | —HARPOON THERAPEUTICS INC | 621,218 | $462.3M | 9.08% |
PreviousPage 2 of 2